What is the Cause of Recurrent Urinary Tract Infection? Contemporary Microscopic Concepts of Pathophysiology

키워드

참고문헌 (75)

1. Suzanne E. Geerlings, "Clinical Presentations and Epidemiology of Urinary Tract Infections", Microbiology Spectrum, 4(5) (2016), American Society for Microbiology[DOI]
2. Dason S, "Guidelines for the diagnosis and management of recurrent urinary tract infection in women", Can Urol Assoc J, 5, pp.316~322 (2011)
3. Kahlmeter G, "An international survey of the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infections: the ECO.SENS Project", J Antimicrob Chemother, 51, pp.69~76 (2003)
4. Ulett GC, "Bacterial pathogenesis : remodelling recurrent infection", Nat Microbiol, 2, pp.16256~ (2016)
5. Murray BE, "Emergence of high-level trimethoprim resistance in fecal Escherichia coli during oral administration of trimethoprim or trimethoprim--sulfamethoxazole", N Engl J Med, 306, pp.130~135 (1982)
6. Martinez JJ, "Type 1 pilus-mediated bacterial invasion of bladder epithelial cells", EMBO J, 19, pp.2803~2812 (2000)
7. Mulvey MA, "Establishment of a persistent Escherichia coli reservoir during the acute phase of a bladder infection", Infect Immun, 69, pp.4572~4579 (2001)
8. Wu XR, "Uroplakins in urothelial biology, function, and disease", Kidney Int, 75, pp.1153~1165 (2009)
9. Schaeffer AJ, "Empiric use of trimethoprim-sulfamethoxazole (TMP-SMX) in the treatment of women with uncomplicated urinary tract infections, in a geographic area with a high prevalence of TMP-SMX-resistant uropathogens", J Urol, 168(4 Pt 1), pp.1652~1653 (2002)
10. Raz R, "Empiric use of trimethoprim-sulfamethoxazole (TMP-SMX)in the treatment of women with uncomplicated urinary tract infections, in a geographical area with a high prevalence of TMP-SMXresistant uropathogens", Clin Infect Dis, 34, pp.1165~1169 (2002)
11. Ley RE, "Ecological and evolutionary forces shaping microbial diversity in the human intestine", Cell, 124, pp.837~848 (2006)
12. Thomas-White K, "The bladder is not sterile : history and current discoveries on the urinary microbiome", Curr Bladder Dysfunct Rep, 11, pp.18~24 (2016)
13. Hans G. Pohl, "The Urine Microbiome of Healthy Men and Women Differs by Urine Collection Method", International Neurourology Journal, 24(1), pp.41~51 (2020), 대한배뇨장애요실금학회[DOI]
14. Pearce MM, "The female urinary microbiome in urgency urinary incontinence", Am J Obstet Gynecol, 213, pp.347~ (2015)
15. Pearce MM, "The female urinary microbiome : a comparison of women with and without urgency urinary incontinence", mBio, 5, pp.e01283~14 (2014)
16. Lewis DA, "The human urinary microbiome; bacterial DNA in voided urine of asymptomatic adults", Front Cell Infect Microbiol, 3, pp.41~ (2013)
17. Khasriya R, "Spectrum of bacterial colonization associated with urothelial cells from patients with chronic lower urinary tract symptoms", J Clin Microbiol, 51, pp.2054~2062 (2013)
18. Brubaker L, "The new world of the urinary microbiota in women", Am J Obstet Gynecol, 213, pp.644~649 (2015)
19. McDonald M, "A head-to-head comparative phase II study of standard urine culture and sensitivity versus DNA next-generation sequencing testing for urinary tract infections", Rev Urol, 19, pp.213~220 (2017)
20. Price TK, "The clinical urine culture : enhanced techniques improve detection of clinically relevant microorganisms", J Clin Microbiol, 54, pp.1216~1222 (2016)
21. Bahadori M, "Genetic relatedness of the Escherichia coli fecal population and strains causing urinary tract infection in the same host", Microbiologyopen, 8, pp.e00759~ (2019)
22. Hashemizadeh Z, "Association between virulence profile, biofilm formation and phylogenetic groups of Escherichia coli causing urinary tract infection and the commensal gut microbiota: a comparative analysis", Microb Pathog, 110, pp.540~545 (2017)
23. Flores-Mireles AL, "Urinary tract infections: epidemiology, mechanisms of infection and treatment options", Nat Rev Microbiol, 13, pp.269~284 (2015)
24. Spaulding CN, "Selective depletion of uropathogenic E. coli from the gut by a FimH antagonist", Nature, 546, pp.528~532 (2017)
25. Lee JR, "Gut microbial community structure and complications after kidney transplantation : a pilot study", Transplantation, 98, pp.697~705 (2014)
26. Magruder M, "Gut uropathogen abundance is a risk factor for development of bacteriuria and urinary tract infection", Nat Commun, 10, pp.5521~ (2019)
27. Cheng Y, "Detection of intracellular bacteria in exfoliated urothelial cells from women with urge incontinence", Pathog Dis (2016)
28. Chen Z, "The urinary microbiome in patients with refractory urge incontinence and recurrent urinary tract infection", Int Urogynecol J, 29, pp.1775~1782 (2018)
29. Hannan TJ, "Host-pathogen checkpoints and population bottlenecks in persistent and intracellular uropathogenic Escherichia coli bladder infection", FEMS Microbiol Rev, 36, pp.616~648 (2012)
30. Rosen DA, "Detection of intracellular bacterial communities in human urinary tract infection", PLoS Med, 4, pp.e329~ (2007)
31. van de Wijgert JH, "The vaginal microbiota : what have we learned after a decade of molecular characterization", PLoS One, 9, pp.e105998~ (2014)
32. van De Wijgert JH, "Intravaginal practices, vaginal flora disturbances, and acquisition of sexually transmitted diseases in Zimbabwean women", J Infect Dis, 181, pp.587~594 (2000)
33. Gilbert NM, "Transient microbiota exposures activate dormant Escherichia coli infection in the bladder and drive severe outcomes of recurrent disease", PLoS Pathog, 13, pp.e1006238~ (2017)
34. Butler DSC, "Cytoprotective effect of Lactobacillus crispatus CTV-05 against uropathogenic E. coli", Pathogens, 5, pp.27~ (2016)
35. Rosen DA, "Utilization of an intracellular bacterial community pathway in Klebsiella pneumoniae urinary tract infection and the effects of FimK on type 1 pilus expression", Infect Immun, 76, pp.3337~3345 (2008)
36. Robino L, "Detection of intracellular bacterial communities in a child with Escherichia coli recurrent urinary tract infections", Pathog Dis, 68, pp.78~81 (2013)
37. Elliott TS, "Bacteriology and ultrastructure of the bladder in patients with urinary tract infections", J Infect, 11, pp.191~199 (1985)
38. Dhakal BK, "Mechanisms and consequences of bladder cell invasion by uropathogenic Escherichia coli", Eur J Clin Invest, 38(Suppl 2), pp.2~11 (2008)
39. Wright KJ, "Development of intracellular bacterial communities of uropathogenic Escherichia coli depends on type 1 pili", Cell Microbiol, 9, pp.2230~2241 (2007)
40. Ulett GC, "Functional analysis of antigen 43 in uropathogenic Escherichia coli reveals a role in long-term persistence in the urinary tract", Infect Immun, 75, pp.3233~3244 (2007)
41. Mulvey MA, "Induction and evasion of host defenses by type 1-piliated uropathogenic Escherichia coli", Science, 282, pp.1494~1497 (1998)
42. Schilling JD, "Effect of trimethoprim-sulfamethoxazole on recurrent bacteriuria and bacterial persistence in mice infected with uropathogenic Escherichia coli", Infect Immun, 70, pp.7042~7049 (2002)
43. Kerrn MB, "Intracellular persistence of Escherichia coli in urinary bladders from mecillinam-treated mice", J Antimicrob Chemother, 55, pp.383~386 (2005)
44. Hvidberg H, "Development of a long-term ascending urinary tract infection mouse model for antibiotic treatment studies", Antimicrob Agents Chemother, 44, pp.156~163 (2000)
45. Justice SS, "Differentiation and developmental pathways of uropathogenic Escherichia coli in urinary tract pathogenesis", Proc Natl Acad Sci U S A, 101, pp.1333~1338 (2004)
46. Eto DS, "Integrin-mediated host cell invasion by type 1-piliated uropathogenic Escherichia coli", PLoS Pathog, 3, pp.e100~ (2007)
47. Eto DS, "Actin-gated intracellular growth and resurgence of uropathogenic Escherichia coli", Cell Microbiol, 8, pp.704~717 (2006)
48. Anderson GG, "Intracellular bacterial biofilm-like pods in urinary tract infections", Science, 301, pp.105~107 (2003)
49. Wang ZM, "Dynamin2-and endothelial nitric oxide synthase-regulated invasion of bladder epithelial cells by uropathogenic Escherichia coli", J Cell Biol, 192, pp.101~110 (2011)
50. Duncan MJ, "Bacterial penetration of bladder epithelium through lipid rafts", J Biol Chem, 279, pp.18944~18951 (2004)
51. Bishop BL, "Cyclic AMP-regulated exocytosis of Escherichia coli from infected bladder epithelial cells", Nat Med, 13, pp.625~630 (2007)
52. Mysorekar IU, "Mechanisms of uropathogenic Escherichia coli persistence and eradication from the urinary tract", Proc Natl Acad Sci U S A, 103, pp.14170~14175 (2006)
53. Blango MG, "Forced resurgence and targeting of intracellular uropathogenic Escherichia coli reservoirs", PLoS One, 9, pp.e93327~ (2014)
54. Blango MG, "Persistence of uropathogenic Escherichia coli in the face of multiple antibiotics", Antimicrob. Agents Chemother, 54, pp.1855~1863 (2010)
55. Rackley RR, "Immunoregulatory potential of urothelium : characterization of NF-kappaB signal transduction", J Urol, 162, pp.1812~1816 (1999)
56. Simpson BW, "Lipopolysaccharide transport to the cell surface : biosynthesis and extraction from the inner membrane", Philos Trans R Soc Lond B Biol Sci, 370, pp.20150029~ (2015)
57. Zhang G, "On the essentiality of lipopolysaccharide to Gram-negative bacteria", Curr Opin Microbiol, 16, pp.779~785 (2013)
58. Schilling JD, "CD14-and Toll-like receptor-dependent activation of bladder epithelial cells by lipopolysaccharide and type 1 piliated Escherichia coli", Infect Immun, 71, pp.1470~1480 (2003)
59. Song J, "A novel TLR4-mediated signaling pathway leading to IL-6 responses in human bladder epithelial cells", PLoS Pathog, 3, pp.e60~ (2007)
60. Hunstad DA, "Suppression of bladder epithelial cytokine responses by uropathogenic Escherichia coli", Infect Immun, 73, pp.3999~4006 (2005)
61. Yang Y, "Recent advances in the mechanisms of NLRP3 inflammasome activation and its inhibitors", Cell Death Dis, 10, pp.128~ (2019)
62. Hughes FM Jr, "Inflammasomes are important mediators of cyclophosphamide-induced bladder inflammation", Am J Physiol Renal Physiol, 306, pp.F299~308 (2014)
63. Hughes FM Jr, "The NACHT, LRR and PYD domains-containing protein 3 (NLRP3) inflammasome mediates inflammation and voiding dysfunction in a lipopolysaccharide-induced rat model of cystitis", J Clin Cell Immunol, 7, pp.396~ (2016)
64. Nagamatsu K, "Dysregulation of Escherichia coli alpha-hemolysin expression alters the course of acute and persistent urinary tract infection", Proc Natl Acad Sci U S A, 112, pp.E871~80 (2015)
65. Kline KA, "Immune modulation by group B Streptococcus influences host susceptibility to urinary tract infection by uropathogenic Escherichia coli", Infect Immun, 80, pp.4186~4194 (2012)
66. Meyn LA, "Rectal colonization by group B Streptococcus as a predictor of vaginal colonization", Am J Obstet Gynecol, 201, pp.76~ (2009)
67. Ulett KB, "Diversity of group B streptococcus serotypes causing urinary tract infection in adults", J Clin Microbiol, 47, pp.2055~2060 (2009)
68. O’Brien VP, "Are you experienced? Understanding bladder innate immunity in the context of recurrent urinary tract infection", Curr Opin Infect Dis, 28, pp.97~105 (2015)
69. Engeler DS, "The 2013 EAU guidelines on chronic pelvic pain: is management of chronic pelvic pain a habit, a philosophy, or a science? 10 years of development", Eur Urol, 64, pp.431~439 (2013)
70. Watanabe M, "Trpm7 protein contributes to intercellular junction formation in mouse urothelium", J Biol Chem, 290, pp.29882~29892 (2015)
71. Langermann S, "Prevention of mucosal Escherichia coli infection by FimH-adhesin-based systemic vaccination", Science, 276, pp.607~611 (1997)
72. Thumbikat P, "Antigenspecific responses accelerate bacterial clearance in the bladder", J Immunol, 176, pp.3080~3086 (2006)
73. Jaillon S, "The humoral pattern recognition molecule PTX3 Is a key component of innate immunity against urinary tract infection", Immunity, 40, pp.621~632 (2014)
74. Signoretti S, "p63 regulates commitment to the prostate cell lineage", Proc Natl Acad Sci U S A, 102, pp.11355~11360 (2005)
75. Thumbikat P, "Bacteria-induced uroplakin signaling mediates bladder response to infection", PLoS Pathog, 5, pp.e1000415~ (2009)

관련 논문AI추천